Table 2.
Response | NPLS (175 mg/m2) (N = 85) Arm A, n (%) |
NPLS (80 mg/m2) (N = 45) Arm B, n (%) |
Conventional paclitaxel (175 mg/m2) (N = 44) Arm C, n (%) |
---|---|---|---|
CR | 3 (3.5) | 0 (0) | 0 (0) |
PR | 22 (25.9) | 20 (44.4) | 10 (22.7) |
SD | 41 (48.2) | 18 (40) | 22 (50) |
ORR (CR + PR) | 25 (29.4) | 20 (44.4) | 10 (22.7) |
DCR (CR + PR + SD) | 66 (77.6) | 38 (84.4) | 32 (72.7) |
CR, complete response; DCR, disease control rate; NPLS, nanosomal paclitaxel lipid suspension; ORR, overall response rate; PR, partial response; SD, stable disease.